(Total Views: 219)
Posted On: 02/13/2023 4:15:48 PM
Post# of 20

$FUSN News Article - Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-PSMA I&T, a Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer https://marketwirenews.com/news-releases/fusi...13194.html


My Twitter: WhyteStocks